Endostar, a modified endostatin inhibits non small cell lung cancer cell in vitro invasion through osteopontin-related mechanism
Authors:
- 1 July 2009
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 614 (1-3) , 1-6
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Osteopontin: role in cell signaling and cancer progressionTrends in Cell Biology, 2006
- Increased Expression of Osteopontin Contributes to the Progression of Prostate CancerCancer Research, 2006
- Low Dose Carboplatin Combined With Angiostatic Agents Prevents Metastasis in Human Testicular Germ Cell Tumor XenograftsJournal of Urology, 2003
- Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinomaCancer, 2003
- Osteopontin Induces Nuclear Factor κB-mediated Promatrix Metalloproteinase-2 Activation through IκBα/IKK Signaling Pathways, and Curcumin (Diferulolylmethane) Down-regulates These PathwaysJournal of Biological Chemistry, 2003
- CD44: From adhesion molecules to signalling regulatorsNature Reviews Molecular Cell Biology, 2003
- Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatinInternational Journal of Cancer, 2002
- OsteopontinCritical Reviews in Oral Biology & Medicine, 2000
- Matrix metal loproteinases and the development of cancerChemistry & Biology, 1996
- Ca2+Suppresses Cell Adhesion to Osteopontin by Attenuating Binding Affinity for Integrin αvβ3Journal of Biological Chemistry, 1995